4Hermans MM, van Leenen D, Kroos MA, et al. Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype-phenotype correlation in glycogen storage disease type Ⅱ [J]. Human Mutation, 2004, 23 : 47-56.
5Chien YH, Hwu WL, Lee NC. Pompe disease: early diagnosis and early treatment make a difference [J]. Pediatr Neonatol, 2013, 54: 219-227.
6Winkel LP, Hagemans ML, vaa Doom PA. The natural course of nan-classic Pompe's disease: a review of 225 published cases[J]. J Neurol, 2005, 252: 875-884.
7Huidekoper HH, Visser G, Ackermans MT, et al. A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type la and fructose-l, 6-bisphos- phatase deficiency[J]. J Inher Metab Dis, 2010, 33: 25-31.
8Hagemans ML, Winkel LP, van Doom PA, et al. Clinical mani- festation and natural course of late-onset Pompe's disease in 54 Dutch patients[J]. Brain, 2005, 128: 671-677.
9Werneck LC, Lorenzoni PJ, Kay CSK, et al. Muscle biopsy in Pompe disease[J]. Arq Neuro-Psiquiat, 2013, 71: 284-289.
